1. Akah, P.A., Tayo, F.M.: Interactions of 5-hydroxytryp amine and tricyclic antidepressants in the rat stomach strip and
cjuine-pig ileum. Arch.I' nt.Pharmacodvn. 1985 274: 201¬309.
2. Armstrong, D., Jcpson, J.B.: Pain-producing substance H human inflammatory exudates and plasma. J.Physiol. 1957 İ35 350-370.
3.
Bal
, F.: Normal vc Patolojik Durumlarda Dişcllcrindcki Serotonin (5-HT) Dcğcrlcrindcki Değişiklikler. Doktora Tezi, :986 İstanbul.
4. Baralicri, A., Gagliardi, V., Simonctı. R.: Further studies :Mect of dıphcnylhydantoın sodium on oro facial tissues in
::Tspring
o
f female mice. Bull. Group. Int.Rech.Sc.Slomat. 1972 15: 137-151.
5. Blumerkrant/, M., Asboe-IIansen. G.: Effect of dip-
/
hcnylhydantoin on connective tissue. Acta. Neurol. Scand. 1974 50: 302-306.
6. Bostancı, U., Aksoy, N., Aydın, N.: Phcnyioin ve gingival büyüme. A.Ü. Diş Hek. Fak. Derf>. 1987 14 (3): 313-316.
7. Butıler, R.T., Kalkwarf, K.L., Kaldahl, W.B.: Drug-induced gingival hyperplasia: Phcnyloin eyelosponne and nifedipine. J.A.DA. 1987 114: 56-60,.
8. Francis, L.Iİ.: Melville, KX: Fffcct of diphcnylhydanlo-in on gingival histamine and serotonin. J.Canad. Dent. Assos. 1959 25:608-620.
9. Francis, L.H.: Melville, K.I.: F.ffeclsofdiphcnylhydan-toin (dilantin) on histamine changes in gingival tissue. J.Ca-nad.Dent.Assoc. 1958 24:142-147.
10. Galamb, S., Toth, S.. Terner, K.: The 5-hydroxy try pta-mine level of human gingiva in health, inflammation and pcrio-
12
F. Bal, AH. Rodopman, E. Özalp
dontal disease. Archs. Oral Biol. 1967/2: 1307-1312,.
11. Goebel, R.W.: Sodium diphenyihydanloin association with oral healing. J.OralSurg. 191230: 191-195.
12. HasselL T.M., O'Donnell, J., Pearlman, J.:Phenyloin-induced gingival overgrowth in institutionalized epileptics. J.Clin.Periodontol. 1984 11: 242-253,
13. Hassell, T.M., Page, R.C., Lindhe, J.: Histologic evidence for impaired growth control in diphenyihydanloin gingival overgrowth in man. Archs.Oral Biol. 1978 23: 381-384.
14. Jackson, J.C., Cross, R.J., Walker, R.F.: Influence of serotonin on the immune response. Immunology. 1985 54: 505¬512,.
15. Larmas, L.A., Makinon, K.K., Paunio, K.U.: A histoche-mical study of arylaırujıopeptidases in hydanloin induced hyperplastic, healthy and inflamed human gingiva. J.Periodont.Res. 1973*: 21-27.
16. Lidberg, P., Dahlström, a., Ahlman, II.: On the nature of the contractile motor responses of the rat stomach elicited by serotonin or substance P. J. Neural Transmission. 1985 63: 73-89.
17. Little, T.M., Girgis, S.S.. Masotti, R.E.: Diphenylhydan-toin-induced gingival hyperplasia: Its response to changes in drug dosage. Developmental Med and Child Neurology. 1975 17(4): 421-424.
18. Lucas, R.M., Howell, L.P., Wall, B.A.: Nifedipine-indu-ced gingival hyperplasia. A histochemical and ulirastructural study. J.Periodontol, 198556(4): 211-215,.
19. Lundberg, C, Gerdin, B.: The role of histamine and serotonin in the inflammatory reaction in an experimental model of open wounds in the rat. Scand J.Plast. Reconstr.Surg. 1984 18: 175-180,.
20. Maling, H.M., Webster, M.E., Williams, MA.: Inflammation induced by histamine, serotonin, bradykinin and compound 48/80 in the rat: Antagonists and mechanisms of action. J.Pharmacol. Exp.Ther. 1974 191: 300-310.
21. McGaw, W.T., Porter, H.: Cyclosporine-İnduced gingival overgrowth: An ulirastructural stereologic study. J.Oral. Surg. 1988 65(2): 186-189.
22. Melmon, K.L., Morell, H.F. (cd): Clinical Pharmacology Basic Principles in Therapeutics, MacMilan Pub. Comp.Inc, 1972 New York.
23. Nuki, R., Cooper, S.H.: The role of inflammation in the pathogenesis of gingival enlargement during the administration of diphcnylhydantoin sodium in cats. J.Periodont.Res. 1972 7: 102-110.
24. Oyvin, V.I., Gaponyuk, P.Y.: The mechanism of blood vessel permeability derangement under the influence of histamine, serotonin and bradykinin. Experimentia, 1970 26 (3): 843¬848,.
25.
Özalp
, E.A.: Normal ve Muhtelif Patolojik Hallerde Gin-givalardaki Histamin Miktarlarındaki Değişiklikler. Doktora Tezi. 1972 Istanbul.
26. Page, I.II.: Serotonin (5-hydroxy tryptamine). J.Physi-oLRev. 195835:277.
27. Parratt, J.R., West, C.B.: 5-Hydroxytryptamine and tissue mast cells. J.Physiol. 1957 137: 169-178.
28. Rodin, H.A., Kaslick, R.S., Chascn, A.L: Bradykinin activity in gingival fluid. A Pilot study. J.Dent.Res. 1973 52: 628.
29. Rodopman, A.H.: Normal
v
e Patolojik Durumlarda Dento-Alveolar Dokulardaki Prostaglandin Düzeyi Değişiklikleri. Doktora Tezi, 1983 Istanbul.
30. Rovin, S., Sabes, W.R., Eversolc, L.R.: Diphenyihydanloin sodium (dilanlin) as a caries relaxdcr. J.Dent.Res. 1974 53 (3): 588-591.
31. Shapiro, L., Lodato, F.M.: Endotoxin determination in gingival inflammation. /. Periodontol. 1972 43: 591-596.
32. Sheridorr, PJ., Reeve, CM.: Effective Treatment of dilanlin gingival hyperplasia. J.Oral.Surg. 1973 35 (1): 42-46.
33. Spouge, J.D.: Generalized hyperplasias of the gingiva. "Oral Palhology kitabında", The C.V.Mosby Comp., 1973 Saint Louis.
34. Steinberg, A., Allan, P., Joffays, II.: Distribution and metabolism of diphenylhydantoin in oral and nonoral tissues of ferrets. J.Dent.Res. 1973 52 (2): 267-270.
35. Stinnett, E-, Rodu, B., Grizzle, W.R>: New developments in understanding phenyioin-induced gingival hyperplasia. JA-DA. \9Z1U4: 814-816.
36.
Tahsinoğlu
, M., Çöloğlu, A.S., F.rscnvcn, G.: Genel Patoloji. Prof. Dr. N. Terzioğlu Basım Atölyesi. 1984 Istanbul.
37. Telford, J.M., West, G.B.: Histamine and 5-HT content of tissues after prolonged treatment with polymyxin B. J. Pharm. Pharmacol. 1960 12: 254-255.
38. Theoharides, T.C.. Kracllcr. S.. Bondy, P.K.: Differential release of serotonin without comparable histamine under diverse conditions in the rat mast cell. Biochem. Pharmacol. 1985 34 (9): 1389-1398.
39. Twarog, B.M., Page, L.: Serotonin content of some mammalian tissues and urine and a method its determination. Am.J.Physiol. 1953 175: 157.
40. Vane, J.R.: A Sensitive method for the assay of 5-hydroxytryptamine. Br. J.Pharmacol. 1957 12: 344.
41. Vane, J.R.: The relative activities of some tryptamine analoqucs on the isolated rat stomach strip preparation. Br J.Pharmacol. 1959/4: 87-98.
42. West, G.B.: 5-hydroxy tryptamine and 5-hydroxy tryp-topnan. J.Pharm. Pharmacol 1958 (SuppI 10): 92T.
Thank you for copying data from http://www.arastirmax.com
